Literature DB >> 12931206

Neuronal expression of GFAP in patients with Alzheimer pathology and identification of novel GFAP splice forms.

E M Hol1, R F Roelofs, E Moraal, M A F Sonnemans, J A Sluijs, E A Proper, P N E de Graan, D F Fischer, F W van Leeuwen.   

Abstract

Glial fibrillary acidic protein (GFAP) is considered to be a highly specific marker for glia. Here, we report on the expression of GFAP in neurons in the human hippocampus. Intriguingly, this neuronal GFAP is coded by out-of-frame splice variants and its expression is associated with Alzheimer pathology. We identified three novel GFAP splice forms: Delta 135 nt, Delta exon 6 and Delta 164 nt. Neuronal GFAP is mainly observed in the pyramidal neurons of the hippocampus of Alzheimer and Down syndrome patients and aged controls, but not in neurons of patients suffering from hippocampal sclerosis. Apparently, the hippocampal neurons in patients with Alzheimer's disease pathology are capable of expressing glia-specific genes.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12931206     DOI: 10.1038/sj.mp.4001379

Source DB:  PubMed          Journal:  Mol Psychiatry        ISSN: 1359-4184            Impact factor:   15.992


  57 in total

1.  Age-related decreases in SYN levels associated with increases in MAP-2, apoE, and GFAP levels in the rhesus macaque prefrontal cortex and hippocampus.

Authors:  Gwendolen E Haley; Steven G Kohama; Henryk F Urbanski; Jacob Raber
Journal:  Age (Dordr)       Date:  2010-04-13

2.  A histopathological diagnostic marker for human spinal astrocytoma: expression of glial fibrillary acidic protein-δ.

Authors:  Dong Hwa Heo; Se Hoon Kim; Kyung-Moo Yang; Yong Jun Cho; Keung Nyun Kim; Do Heum Yoon; Tae-Cheon Kang
Journal:  J Neurooncol       Date:  2012-02-09       Impact factor: 4.130

3.  Synergistic effect of retinoic acid and cytokines on the regulation of glial fibrillary acidic protein expression.

Authors:  Federico Herrera; Qi Chen; David Schubert
Journal:  J Biol Chem       Date:  2010-09-28       Impact factor: 5.157

Review 4.  GFAP and its role in Alexander disease.

Authors:  Roy A Quinlan; Michael Brenner; James E Goldman; Albee Messing
Journal:  Exp Cell Res       Date:  2007-04-06       Impact factor: 3.905

5.  Subventricular zone neural progenitors from rapid brain autopsies of elderly subjects with and without neurodegenerative disease.

Authors:  Brian W Leonard; Diego Mastroeni; Andrew Grover; Qiang Liu; Kechun Yang; Ming Gao; Jie Wu; David Pootrakul; Simone A van den Berge; Elly M Hol; Joseph Rogers
Journal:  J Comp Neurol       Date:  2009-07-20       Impact factor: 3.215

6.  Intermediate filament transcription in astrocytes is repressed by proteasome inhibition.

Authors:  Jinte Middeldorp; Willem Kamphuis; Jacqueline A Sluijs; Dalila Achoui; Cathalijn H C Leenaars; Matthijs G P Feenstra; Paula van Tijn; David F Fischer; Celia Berkers; Huib Ovaa; Roy A Quinlan; Elly M Hol
Journal:  FASEB J       Date:  2009-03-30       Impact factor: 5.191

7.  Comparison of cellular architecture, axonal growth, and blood vessel formation through cell-loaded polymer scaffolds in the transected rat spinal cord.

Authors:  Nicolas N Madigan; Bingkun K Chen; Andrew M Knight; Gemma E Rooney; Eva Sweeney; Lisa Kinnavane; Michael J Yaszemski; Peter Dockery; Timothy O'Brien; Siobhan S McMahon; Anthony J Windebank
Journal:  Tissue Eng Part A       Date:  2014-08-11       Impact factor: 3.845

Review 8.  Intermediate filaments: primary determinants of cell architecture and plasticity.

Authors:  Harald Herrmann; Sergei V Strelkov; Peter Burkhard; Ueli Aebi
Journal:  J Clin Invest       Date:  2009-07-01       Impact factor: 14.808

9.  Identification of a novel vimentin promoter and mRNA isoform.

Authors:  Zhangle Zhou; Søren Kahns; Anders Lade Nielsen
Journal:  Mol Biol Rep       Date:  2009-08-19       Impact factor: 2.316

10.  Specific human astrocyte subtype revealed by affinity purified GFAP antibody; unpurified serum cross-reacts with neurofilament-L in Alzheimer.

Authors:  Jinte Middeldorp; Simone A van den Berge; Eleonora Aronica; Dave Speijer; Elly M Hol
Journal:  PLoS One       Date:  2009-11-04       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.